GoodRx Holdings, Inc. (GDRX)
2.63
-0.09
(-3.31%)
USD |
NASDAQ |
Dec 09, 11:41
GoodRx Holdings EPS Diluted (Quarterly): 0.0032 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Spok Holdings, Inc. | 0.1523 |
| DarioHealth Corp. | -3.052 |
| National Research Corp. | 0.1805 |
| Predictive Oncology, Inc. | -107.25 |
| Certara, Inc. | 0.0095 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.119M |
| Revenue (Quarterly) | 196.03M |
| Total Expenses (Quarterly) | 194.91M |
| Enterprise Value | 1.195B |
| Gross Profit Margin (Quarterly) | 82.22% |
| Profit Margin (Quarterly) | 0.57% |
| Earnings Yield | 3.27% |
| Operating Earnings Yield | 11.39% |
| Normalized Earnings Yield | 5.228 |